# OnCo record paper-mansoori-mebendazole-gi-cancer-phase-2a-sci-rep-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mansoori-mebendazole-gi-cancer-phase-2a-sci-rep-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mansoori-mebendazole-gi-cancer-phase-2a-sci-rep-2021" ;
  schema:name "A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer"@en ;
  schema:description "A Swedish trial gave mebendazole to ten people with advanced bowel and stomach cancers that had stopped responding to treatment; it was safe, but every patient's cancer kept growing, four of them unusually fast."@en ;
  schema:url <https://onco.cc/key-papers/paper-mansoori-mebendazole-gi-cancer-phase-2a-sci-rep-2021/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41598-021-88433-y>, <https://pubmed.ncbi.nlm.nih.gov/33903692/> ;
  schema:sameAs <https://doi.org/10.1038/s41598-021-88433-y> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Mansoori S, Fryknäs M, Alvfors C, Loskog A, Larsson R, Nygren P." ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/drug-repurposing/> ;
  onco:drugs <https://onco.cc/drugs/mebendazole/> ;
  onco:terms <https://onco.cc/terms/single-arm/> .